Julie Person
Hoofd Administratief Officier bij THIRD HARMONIC BIO, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Julie Person
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
THIRD HARMONIC BIO, INC. | Hoofd Administratief Officier | 01-06-2022 | - |
Loopbaan van Julie Person
Eerdere bekende functies van Julie Person
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NEUMORA THERAPEUTICS, INC. | Human Resources Officer | 01-01-2021 | 01-06-2022 |
SANGAMO THERAPEUTICS, INC. | Human Resources Officer | 01-03-2019 | 01-04-2020 |
SHIRE | Human Resources Officer | 01-02-2017 | 01-03-2019 |
AUDENTES THERAPEUTICS, INC. | Human Resources Officer | - | - |
Opleiding van Julie Person
St. Mary's College of California | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Ierland | 2 |
Operationeel
Human Resources Officer | 4 |
Chief Administrative Officer | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
THIRD HARMONIC BIO, INC. | Health Technology |
NEUMORA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Julie Person
- Ervaring